Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.
- Published In:
- Lancet (London, England), 403(10437), 1635-1648 (2024)
- Authors:
- Butler, Javed(16), Shah, Sanjiv J(11), Petrie, Mark C(15), Borlaug, Barry A, Abildstrøm, Steen Z, Davies, Melanie J, Hovingh, G Kees, Kitzman, Dalane W, Møller, Daniél Vega, Verma, Subodh, Einfeldt, Mette Nygaard, Lindegaard, Marie L, Rasmussen, Søren, Abhayaratna, Walter, Ahmed, Fozia Z, Ben-Gal, Tuvia, Chopra, Vijay, Ezekowitz, Justin A, Fu, Michael, Ito, Hiroshi, Lelonek, Małgorzata, Melenovský, Vojtěch, Merkely, Bela, Núñez, Julio, Perna, Eduardo, Schou, Morten, Senni, Michele, Sharma, Kavita, van der Meer, Peter, Von Lewinski, Dirk, Wolf, Dennis, Kosiborod, Mikhail N
- Database ID:
- RPEP-07904
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-07904APA
Butler, Javed; Shah, Sanjiv J; Petrie, Mark C; Borlaug, Barry A; Abildstrøm, Steen Z; Davies, Melanie J; Hovingh, G Kees; Kitzman, Dalane W; Møller, Daniél Vega; Verma, Subodh; Einfeldt, Mette Nygaard; Lindegaard, Marie L; Rasmussen, Søren; Abhayaratna, Walter; Ahmed, Fozia Z; Ben-Gal, Tuvia; Chopra, Vijay; Ezekowitz, Justin A; Fu, Michael; Ito, Hiroshi; Lelonek, Małgorzata; Melenovský, Vojtěch; Merkely, Bela; Núñez, Julio; Perna, Eduardo; Schou, Morten; Senni, Michele; Sharma, Kavita; van der Meer, Peter; Von Lewinski, Dirk; Wolf, Dennis; Kosiborod, Mikhail N. (2024). Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.. Lancet (London, England), 403(10437), 1635-1648. https://doi.org/10.1016/S0140-6736(24)00469-0
MLA
Butler, Javed, et al. "Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials.." Lancet (London, 2024. https://doi.org/10.1016/S0140-6736(24)00469-0
RethinkPeptides
RethinkPeptides Research Database. "Semaglutide versus placebo in people with obesity-related he..." RPEP-07904. Retrieved from https://rethinkpeptides.com/research/butler-2024-semaglutide-versus-placebo-in
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.